富士莱(301258)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301258 富士莱

已收盘 08-28 15:00:00

{"stockData":{"symbol":"301258","market":"SZ","secType":"STK","nameCN":"富士莱","latestPrice":26.13,"timestamp":1787900589000,"preClose":26.16,"halted":0,"volume":651500,"delay":0,"changeRate":-0.0011,"floatShares":91136000,"shares":91670000,"eps":0.0721,"marketStatus":"已收盘","change":-0.03,"latestTime":"08-28 15:00:00","open":26.11,"high":26.26,"low":25.94,"amount":17003700,"amplitude":0.0122,"askPrice":26.14,"askSize":19,"bidPrice":26.13,"bidSize":22,"shortable":0,"etf":0,"ttmEps":0.0721,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":5,"adr":0,"adjPreClose":26.16,"symbolType":"stock","openAndCloseTimeList":[[1787880600000,1787887800000],[1787893200000,1787900400000]],"highLimit":28.78,"lowLimit":23.54,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":91670000,"isCdr":false,"pbRate":1.31,"roa":"--","peRate":362.413315,"roe":"--","epsLYR":0.71,"committee":-0.555556,"marketValue":2395000000,"turnoverRate":0.0071,"status":1,"floatMarketCap":2381000000},"requestUrl":"/m/hq/s/301258","defaultTab":"news","newsList":[{"id":"2662736198","title":"富士莱（301258）披露2026年半年度业绩说明会安排，8月25日股价上涨0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736198","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662736198?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:57","pubTimestamp":1787655465,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，富士莱报收于26.17元，较前一交易日上涨0.42%，最新总市值为23.99亿元。该股当日开盘25.8元，最高26.25元，最低25.1元，成交额达3846.97万元，换手率为1.64%。近日，苏州富士莱医药股份有限公司在巨潮资讯网披露《2026年半年度报告》，并公告将于2026年8月26日下午15:00-16:30在“富士莱投资者关系”小程序举行2026年半年度网上业绩说明会，采用网络远程方式举行，投资者可通过微信小程序或扫码参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500040190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662773332","title":"富士莱(301258)7月31日股东户数0.87万户，较上期增加4.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662773332","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662773332?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:57","pubTimestamp":1787651859,"startTime":"0","endTime":"0","summary":"证券之星消息，近日富士莱披露，截至2026年7月31日公司股东户数为8706.0户，较7月10日增加381.0户，增幅为4.58%。在化学制药行业个股中，富士莱股东户数低于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.68万户。从股价来看，2026年7月10日至2026年7月31日，富士莱区间跌幅为2.88%，在此期间股东户数增加381.0户，增幅为4.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500038019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820325","title":"图解富士莱中报：第二季度单季净利润同比下降161.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820325","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662820325?lang=zh_cn&edition=full","pubTime":"2026-08-25 02:46","pubTimestamp":1787597189,"startTime":"0","endTime":"0","summary":"证券之星消息，富士莱2026年中报显示，上半年度公司主营收入1.85亿元，同比下降17.17%；归母净利润-1461.71万元，同比下降133.93%；扣非净利润-2007.48万元，同比下降380.19%；其中2026年第二季度，公司单季度主营收入9260.73万元，同比下降16.44%；单季度归母净利润-1184.94万元，同比下降161.91%；单季度扣非净利润-1355.96万元，同比下降359.71%；负债率10.17%，投资收益1906.84万元，财务费用498.94万元，毛利率14.0%。财报数据概要请见下图:本文数据来源于富士莱2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657051517","title":"富士莱(301258)7月31日股东户数0.87万户，较上期增加4.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657051517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657051517?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:46","pubTimestamp":1785923219,"startTime":"0","endTime":"0","summary":"证券之星消息，近日富士莱披露，截至2026年7月31日公司股东户数为8706.0户，较7月10日增加381.0户，增幅为4.58%。在化学制药行业个股中，富士莱股东户数低于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.59万户。从股价来看，2026年7月10日至2026年7月31日，富士莱区间跌幅为2.88%，在此期间股东户数增加381.0户，增幅为4.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657514474","title":"富士莱：截至2026年7月31日股东总户数为8,706户","url":"https://stock-news.laohu8.com/highlight/detail?id=2657514474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657514474?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:45","pubTimestamp":1785919516,"startTime":"0","endTime":"0","summary":"证券之星消息，富士莱(301258)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止7月31日，公司股东户数是多少？富士莱回复：尊敬的投资者，您好！截至2026年7月31日股东总户数为8,706户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500030342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651179522","title":"富士莱(301258)7月10日股东户数0.83万户，较上期增加1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651179522","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651179522?lang=zh_cn&edition=full","pubTime":"2026-07-14 17:27","pubTimestamp":1784021279,"startTime":"0","endTime":"0","summary":"证券之星消息，近日富士莱披露，截至2026年7月10日公司股东户数为8325.0户，较6月30日增加104.0户，增幅为1.27%。在化学制药行业个股中，富士莱股东户数低于行业平均水平，截至7月10日，化学制药行业平均股东户数为3.56万户。从股价来看，2026年6月30日至2026年7月10日，富士莱区间涨幅为5.4%，在此期间股东户数增加104.0户，增幅为1.27%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400033527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651196178","title":"富士莱：截至2026年7月10日股东总户数为8,325户","url":"https://stock-news.laohu8.com/highlight/detail?id=2651196178","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651196178?lang=zh_cn&edition=full","pubTime":"2026-07-14 15:42","pubTimestamp":1784014934,"startTime":"0","endTime":"0","summary":"证券之星消息，富士莱(301258)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止到七月十日股东人数是多少啊？谢谢富士莱回复：尊敬的投资者，您好！截至2026年7月10日股东总户数为8,325户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400025426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650024907","title":"富士莱：公司CDMO业务正在持续推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2650024907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650024907?lang=zh_cn&edition=full","pubTime":"2026-07-10 15:04","pubTimestamp":1783667052,"startTime":"0","endTime":"0","summary":"证券之星消息，富士莱(301258)07月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司CDMO是否有订单了？富士莱回复：尊敬的投资者，您好！公司CDMO业务正在持续推进中，相关情况请以公司在指定信息披露媒体发布的定期报告及相关公告内容为准。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000021099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649467659","title":"股市必读：富士莱(301258)股东户数0.82万户，较上期增加1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649467659","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649467659?lang=zh_cn&edition=full","pubTime":"2026-07-07 02:40","pubTimestamp":1783363222,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，富士莱报收于25.08元，上涨1.66%，换手率1.13%，成交量1.0万手，成交额2512.16万元。股本股东变化：截至2026年6月30日股东户数为8221.0户，较6月18日增长1.96%，户均持股降至1.12万股。股本股东变化股东户数变动截至2026年6月30日公司股东户数为8221.0户，较6月18日增加158.0户，增幅为1.96%；户均持股数量由1.14万股减少至1.12万股，户均持股市值为25.39万元。截至2026年6月30日股东总户数为8,221户，感谢您对公司的关注！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700001235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649620517","title":"富士莱（301258）披露完成补选第五届董事会非独立董事公告，7月6日股价上涨1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649620517","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649620517?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:51","pubTimestamp":1783349472,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，富士莱报收于25.08元，较前一交易日上涨1.66%，最新总市值为22.99亿元。近日，苏州富士莱医药股份有限公司发布《关于完成补选第五届董事会非独立董事的公告》。董事会中兼任高级管理人员及职工代表董事人数未超过董事总数的二分之一，符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600037930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649446396","title":"富士莱：截至2026年6月30日股东总户数为8,221户","url":"https://stock-news.laohu8.com/highlight/detail?id=2649446396","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649446396?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:54","pubTimestamp":1783324452,"startTime":"0","endTime":"0","summary":"证券之星消息，富士莱(301258)07月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止到六月三十号股东人数是多少啊？谢谢富士莱回复：尊敬的投资者，您好！截至2026年6月30日股东总户数为8,221户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600018418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649641259","title":"富士莱：山东项目已建成10条原料药及医药中间体生产线","url":"https://stock-news.laohu8.com/highlight/detail?id=2649641259","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649641259?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:39","pubTimestamp":1783323549,"startTime":"0","endTime":"0","summary":"证券之星消息，富士莱(301258)07月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司山东项目规划的主要生产哪几类药？富士莱回复：尊敬的投资者，您好！山东项目已建成10条原料药及医药中间体生产线，后续通过高效调试与试生产，将快速实现产能释放，加快公司新产品管线的产业化进程，同时提供更全面、更灵活的CMO/CDMO产能以满足国内外市场需求，持续增强公司的市场竞争力。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600016072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK0239","BK1574","BK1515","09939","301258","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648352462","title":"股市必读：富士莱（301258）7月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648352462","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648352462?lang=zh_cn&edition=full","pubTime":"2026-07-02 06:14","pubTimestamp":1782944059,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，富士莱报收于23.88元，上涨4.87%，换手率1.26%，成交量1.13万手，成交额2639.36万元。董秘最新回复投资者： 请问公司山东CMO/CDMO 项目什么时候试生产？该项目已达到预定可使用状态，目前正全力以赴进行生产线调试、试生产各项工作，有序推进CMO/CDMO业务。相关情况请以公司在指定信息披露媒体发布的定期报告及相关公告内容为准。当日关注点交易信息汇总：7月1日主力资金净流入10.31万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200002787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648515947","title":"富士莱：该项目已达到预定可使用状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2648515947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648515947?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:21","pubTimestamp":1782894071,"startTime":"0","endTime":"0","summary":"证券之星消息，富士莱(301258)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司山东CMO/CDMO 项目什么时候试生产？这个项目是否有新药研发的相关配套？富士莱回复：尊敬的投资者，您好！该项目已达到预定可使用状态，目前正全力以赴进行生产线调试、试生产各项工作，有序推进CMO/CDMO业务。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100030559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645397498","title":"富士莱：6月22日卞爱进、陆建刚减持股份合计7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645397498","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645397498?lang=zh_cn&edition=full","pubTime":"2026-06-23 21:01","pubTimestamp":1782219713,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月23日市场公开信息、上市公司公告及交易所披露数据整理，富士莱最新董监高及相关人员股份变动情况：2026年6月22日公司董秘,董事,高管卞爱进、董事陆建刚共减持公司股份7.0万股，占公司总股本为0.0763%。富士莱近半年内的董监高及核心技术人员增减持详情如下：富士莱的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入92.13万，融资余额增加；融券净流入1100.0，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300040553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645882093","title":"富士莱(301258)6月18日股东户数0.81万户，较上期减少1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645882093","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645882093?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:46","pubTimestamp":1782208000,"startTime":"0","endTime":"0","summary":"证券之星消息，近日富士莱披露，截至2026年6月18日公司股东户数为8063.0户，较6月10日减少100.0户，减幅为1.23%。在化学制药行业个股中，富士莱股东户数低于行业平均水平，截至6月18日，化学制药行业平均股东户数为3.54万户。从股价来看，2026年6月10日至2026年6月18日，富士莱区间跌幅为3.53%，在此期间股东户数减少100.0户，减幅为1.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300030719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645795881","title":"富士莱：截至2026年6月18日股东总户数为8,063户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645795881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645795881?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:45","pubTimestamp":1782204325,"startTime":"0","endTime":"0","summary":"证券之星消息，富士莱(301258)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止到六月二十号股东人数是多少啊？谢谢富士莱回复：尊敬的投资者，您好！截至2026年6月18日股东总户数为8,063户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300028263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644082508","title":"富士莱（301258）披露关于部分募投项目结项并将节余募集资金永久补充流动资金的议案，6月18日股价下跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644082508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644082508?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:59","pubTimestamp":1781794750,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，富士莱报收于24.06元，较前一交易日下跌0.17%，最新总市值为22.06亿元。该股当日开盘24.34元，最高24.45元，最低23.73元，成交额达1730.67万元，换手率为0.81%。近日，苏州富士莱医药股份有限公司发布《关于召开2026年第二次临时股东会的通知》。会议将审议《关于部分募投项目结项并将节余募集资金永久补充流动资金的议案》和《关于补选第五届董事会非独立董事的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800043112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644270461","title":"富士莱最新公告：全资子公司拟出资4800万元参与设立创业投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2644270461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644270461?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:51","pubTimestamp":1781776294,"startTime":"0","endTime":"0","summary":"富士莱(301258.SZ)公告称，公司全资子公司贝格资本拟出资4800万元，与龙驹东方、张卫东共同设立苏州龙驹东格创业投资合伙企业(有限合伙)，贝格资本占认缴出资总额的48%。该基金规模为1亿元，专注投资战略性新兴产业，投资阶段以成长期至Pre-IPO为主。本次投资不构成关联交易，资金来源为自有资金。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800031917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644607717","title":"股市必读：富士莱（301258）6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644607717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644607717?lang=zh_cn&edition=full","pubTime":"2026-06-17 04:38","pubTimestamp":1781642292,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，富士莱报收于24.74元，下跌0.6%，换手率0.86%，成交量7675.0手，成交额1884.35万元。董秘最新回复投资者： 公司大幅破发50%以上后没有任何措施是不是表示公司不重视市值管理？公司高度重视市值管理工作，将持续聚焦主业提升公司核心竞争力，推动企业高质量发展，同时强化投资者关系管理，实施稳定的分红政策，切实维护全体股东利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700003808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301258","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788012174008,"stockEarnings":[{"period":"1week","weight":-0.0136},{"period":"1month","weight":0.0477},{"period":"3month","weight":-0.0095},{"period":"6month","weight":-0.2503},{"period":"1year","weight":-0.2355},{"period":"ytd","weight":-0.1896}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.0323},{"period":"3month","weight":-0.0286},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0283},{"period":"ytd","weight":-0.0042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"苏州富士莱医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8706人(较上一季度增加4.58%)","perCapita":"10468股","listingDate":"2022-03-29","address":"江苏省苏州市常熟市新材料产业园海旺路16号","registeredCapital":"9167万元","survey":"　　苏州富士莱医药股份有限公司的主营业务是医药中间体、原料药及保健品原料的研发、生产和销售。公司的主要产品是硫辛酸系列、磷脂酰胆碱系列、肌肽系列、艾瑞昔布原料药。","listedPrice":48.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"富士莱(301258)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供富士莱(301258)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"富士莱,301258,富士莱股票,富士莱股票老虎,富士莱股票老虎国际,富士莱行情,富士莱股票行情,富士莱股价,富士莱股市,富士莱股票价格,富士莱股票交易,富士莱股票购买,富士莱股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"富士莱(301258)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供富士莱(301258)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}